201 related articles for article (PubMed ID: 17199722)
1. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
Tavintharan S; Lim SC; Chan YH; Sum CF
Diabetes Obes Metab; 2007 Jan; 9(1):81-6. PubMed ID: 17199722
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Donnelly LA; Palmer CN; Whitley AL; Lang CC; Doney AS; Morris AD; Donnan PT
Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
[TBL] [Abstract][Full Text] [Related]
3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
5. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
6. Identification of genetic variants associated with response to statin therapy.
Mega JL; Morrow DA; Brown A; Cannon CP; Sabatine MS
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1310-5. PubMed ID: 19667110
[TBL] [Abstract][Full Text] [Related]
7. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
Ilveskoski E; Lehtimäki T; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Laippala P; Karhunen PJ; Knuuti J
Scand J Clin Lab Invest; 2007; 67(7):723-34. PubMed ID: 17852827
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
9. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
Ying S; Sun YM; Liu XM; An CY; Gao YY
Biochem Biophys Res Commun; 2007 Nov; 363(2):395-8. PubMed ID: 17870053
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C.
Miller M; Dobs A; Yuan Z; Battisti WP; Borisute H; Palmisano J
Curr Med Res Opin; 2004 Jul; 20(7):1087-94. PubMed ID: 15265253
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of apoE polymorphism in Chinese Yunnan Dehong Dai ethnic group].
Tang H; Yan X; Hua Y; Wei M; Zhang L; Gao J; Dong H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):224-6. PubMed ID: 15793794
[TBL] [Abstract][Full Text] [Related]
12. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
[TBL] [Abstract][Full Text] [Related]
13. The influence of apolipoprotein B and E gene polymorphisms on the response to simvastatin therapy in patients with hyperlipidemia.
Ye P; Shang Y; Ding X
Chin Med Sci J; 2003 Mar; 18(1):9-13. PubMed ID: 12901521
[TBL] [Abstract][Full Text] [Related]
14. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
[TBL] [Abstract][Full Text] [Related]
15. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
[TBL] [Abstract][Full Text] [Related]
16. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
Bhavani AB; Sastry KB; Reddy NK; Padma T
Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
Assmann G; Schulte H; Cullen P; Neiss A; Bestehorn K
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):85-91. PubMed ID: 17318766
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
Rontu R; Ojala P; Hervonen A; Goebeler S; Karhunen PJ; Nikkilä M; Kunnas T; Jylhä M; Eklund C; Hurme M; Lehtimäki T
Clin Endocrinol (Oxf); 2006 Mar; 64(3):265-70. PubMed ID: 16487435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]